Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.650
-0.130 (-7.30%)
At close: Feb 12, 2026, 4:00 PM EST
1.650
0.00 (0.00%)
After-hours: Feb 12, 2026, 4:00 PM EST

Indaptus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5.835.7913.369.6339.131.64
Short-Term Investments
---16.81--
Cash & Short-Term Investments
5.835.7913.3626.4339.131.64
Cash Growth
-21.07%-56.69%-49.45%-32.45%2289.75%-56.90%
Other Receivables
----0.02-
Receivables
----0.02-
Prepaid Expenses
0.610.680.620.730.960.01
Other Current Assets
00.150.020.080.280.08
Total Current Assets
6.446.621427.2440.391.73
Property, Plant & Equipment
0.010.080.170.080.170
Other Long-Term Assets
0.390.640.750.740.020.04
Total Assets
6.847.3414.9228.0640.581.78
Accounts Payable
0.710.870.811.382.540.16
Accrued Expenses
1.522.441.871.971.970.24
Current Portion of Leases
0.010.080.10.080.1-
Other Current Liabilities
-----1.62
Total Current Liabilities
2.233.392.773.434.62.02
Long-Term Leases
--0.07-0.07-
Total Liabilities
2.233.392.853.434.682.02
Common Stock
0.020.120.080.080.080.02
Additional Paid-In Capital
77.7664.2657.4154.4451.497.69
Retained Earnings
-73.18-60.44-45.42-29.99-15.67-7.96
Comprehensive Income & Other
---0.1--
Total Common Equity
4.613.9412.0824.6335.9-0.25
Shareholders' Equity
4.613.9412.0824.6335.9-0.24
Total Liabilities & Equity
6.847.3414.9228.0640.581.78
Total Debt
0.010.080.180.080.17-
Net Cash (Debt)
5.825.713.1926.3538.961.64
Net Cash Growth
-20.02%-56.76%-49.96%-32.37%2279.41%-56.90%
Net Cash Per Share
9.4717.0743.9589.31266.7023.58
Filing Date Shares Outstanding
1.750.520.30.30.290.73
Total Common Shares Outstanding
1.640.430.30.30.290.73
Working Capital
4.23.2211.2223.8135.78-0.28
Book Value Per Share
2.819.1940.2582.09121.71-0.34
Tangible Book Value
4.613.9412.0824.6335.9-0.25
Tangible Book Value Per Share
2.819.1940.2582.09121.71-0.34
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q